ABCG2 and cancer: In line with this notion, the somatic mutation R482G, a mutation that frequently occurs in drug-resistant cancer cells, has been associated with an altered ABCG2 substrate spectrum, e.g., with respect to cytotoxic drugs (Sarkadi et al., 2006).